7111US Scl-70 (FDA cleared)

Intended Use:

AESKULISA Scl-70 is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against Scl-70 (70 kDa scleroderma antigen) in human serum.

Recombinant Antigens:


Native Antigens:


Kit Configuration

Method: Elisa
Reference: 7111US
Description: Scl-70 (FDA cleared)
Kit Configuration: Single - G
Cut Off: 15
Range: 0 - 300 U/ml
Standard: CDC
Antibodies: IgG


Material Safety Data Sheet

7111US Material Safety Data Sheet (US)

Customer Related Downloads

We provide Instruction Manuals and Marketing Material for our registered customers only.

Please sign in with your Username and Password or contact This email address is being protected from spambots. You need JavaScript enabled to view it. for a Login Request.